Wednesday, July 8, 2026

pharma · Ovarian Cancer · Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer · ANIX

Anixa Biosciences

Anixa Biosciences trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

San Jose, USA HQ
1982 Founded
12 Employees
Public company Type
ANIX · NYSE Ticker
Company details
Status
Public
HQ
San Jose, USA
Founded
1982
Employees
12
Programs
2
Drugs
4
Patents
1
Intelligence · Clinical Trials

Anixa Biosciences clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Anixa Biosciences programs — each row shows trial ID, program name, phase, status, and indication.

Anixa Biosciences trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Anixa Biosciences.

  1. α-lactalbumin vaccine — Phase 1

    Clinical update
  2. Follicle Stimulating Hormone Receptor T Cells — Phase 1

    Clinical update

Trial registry

2 studies